sub field
BiotechLongevity
About
Wei-Wu He, Ph.D., is a biotech entrepreneur and life sciences investor who founded Emerging Technology Partners (ETP) in 2000 and OriGene Technologies. He serves as Executive Chairman of Human Longevity, Inc. and is the majority owner (53%) and former CEO of CASI Pharmaceuticals. Based in the San Francisco Bay Area, he bridges cross-border biotech investment between the US and China with a focus on longevity and innovative therapeutics.
Areas of interest
longevitygenomicsbiotechoncologylife sciences infrastructurecross-border US-China investingpharmaceuticalshealth span extensiongene expression technologiesprecision medicine